NCT03848910

Brief Summary

The aim of this clinical investigation is to investigate the subject´s overall preference, hearing performance and self-reported assessments with the Investigational device and its precursor Sound Processor (Comparator) after 6 weeks in subjects with conductive/mixed hearing loss or Single Sided Deafness, (SSD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2019

Completed
11 days until next milestone

Study Start

First participant enrolled

February 19, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 21, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 23, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 23, 2019

Completed
10 months until next milestone

Results Posted

Study results publicly available

February 5, 2020

Completed
Last Updated

October 14, 2021

Status Verified

January 1, 2020

Enrollment Period

2 months

First QC Date

February 8, 2019

Results QC Date

December 16, 2019

Last Update Submit

October 13, 2021

Conditions

Outcome Measures

Primary Outcomes (14)

  • Abbreviated Profile of Hearing Aid Benefit (APHAB)

    Measuring of subscales Ease of communication, Reverberation, Background noise, Aversiveness and a Global score with the precursor sound processor at Day 0 and with the Investigational device after 6 weeks with a questionnaire. All subscales range from 0-100%, total score is the average of all subscales 0-100%, where 0% indicates no problems and 100% indicates always problem. A decrease in the APHAB values indicates an improvement. The change from visit 1 with the precursor sound processor to visit 3 with the Investigational device is presented. A positive value indicates an improvement with the Investigational device, a negative value an impairment.

    Day 0 (Visit 1) and after 6 weeks (Visit 3)

  • Speech, Spatial, and Qualities of Hearing Scale (SSQ)

    Measuring speech, spatial and hearing experiences with the precursor sound processor at Day 0 (Visit 1) and with Investigational device after 6 weeks (Visit 3) with a questionnaire. The Total score summarizes the parameters speech, spatial and hearing. A scale from 0 to 10, where 0 represents "can not hear at all", and 10 "hear perfectly" is used. An increase of a SSQ value reflects an improvement. The change from visit 1 with the precursor sound processor to visit 3 with the Investigational device is presented. A positive value indicates an improvement and a negative value an impairment.

    Day 0 and after 6 weeks

  • Self-reported Assessment Regarding Satisfaction and Usability (QUEST Version 2)

    Measuring QUEST (Self-reported assessment regarding satisfaction and usability) using a questionnaire, with the precursor sound processor at Day 0 (Visit 1) and with the Investigational device after 6 weeks (Visit 3). The QUEST form displays the scoring of 8 satisfaction items. The satisfaction items related to the characteristics of the device are: 1) dimensions, 2) weight, 3) adjustments, 4) safety, 5) durability, 6) simplicity of use, 7) comfort and 8) effectiveness. A scale from 1 to 5, where 1 represent not satisfied at all, 2 not very satisfied, 3 more or less satisfied, 4 quiet satisfied and 5 represents very satisfied. The three most important items of 1) dimensions, 2) weight, 3) adjustments, 4) safety, 5) durability, 6) simplicity of use, 7) comfort and 8) effectiveness were listed by each participant.

    Day 0 and after 6 weeks

  • Audiometric Thresholds in Freefield, Pure Tone Average 4 (PTA4)

    To measure threshold audiometry PTA4 (mean of 500, 1000, 2000 and 4000 Hz) with both the precursor sound processor and the Investigational device. The units reported for PTA4 are decibels (dB). The change from visit 1 with the precursor sound processor to visit 3 with the Investigational device is presented. As such, a lower or more negative score is more desirable and reflects a better ability to hear softer sounds.

    Baseline at visit 1, 6 weeks after study start at visit 3

  • Audiometric Thresholds in Freefield, Individual Frequencies

    To measure threshold audiometry at individual frequencies 250, 500, 1000, 2000, 3000, 4000, 6000 Hz with both the precursor sound processor and the Investigational device. The units reported for threshold audiometry are decibels (dB). The change from visit 1 with the precursor sound processor to visit 3 with the Investigational device is presented. As such, a lower or more negative score is more desirable and reflects a better ability to hear softer sounds.

    6 weeks after study start

  • Adaptive Speech Recognition in Noise Ratio

    To measure Adaptive speech recognition in noise with the precursor sound processor and the Investigational device. Measured as signal to noise ratio The adaptive speech test in noise was conducted using validated lists of phonetically balanced sentences, with speech and noise presented from the front (0 degrees azimuth). The speech is kept constant at 65 dB Sound Pressure Level (SPL) and the noise is adapted in dB steps to establish the speech-to-noise ratio (SNR) providing a 50% level of understanding. A ratio of 1 reflects the ability to correctly hear sentences at 65 dB, in the presence of 65 dB background noise. A lower ratio than 1 reflects the ability to correctly hear sentences below 65 dB. A ratio higher than 1 reflects the ability to correctly hear sentences presented above 65 dB. A lower or more negative score is more desirable and represent a better hearing in a noisy environment.

    Baseline at visit 1, 6 weeks after study start at visit 3

  • Speech in Quiet

    To measure Speech in quiet at 50, 65 and 80 dB with the precursor sound processor and the Investigational device. Speech in Quiet presents a list of words in a quiet environment at three different presentations levels, 50, 65 and 80 dB (decibel). The number of correct words perceived at each presentation level are counted and the percentage in relation to the total presented amount of words is calculated. A higher score reflects a higher percentage of correct words perceived, i.e. better hearing in a quiet environment.

    Baseline at visit 1, 6 weeks after study start at visit 3

  • To Compare the Subject´s Overall Preference Regarding the Investigational Device and the Precursor Sound Processor

    The test subject will be asked a question regarding preferred choice made by selection between Investigational device and the precursor sound processor (comparator). Three boxes can be ticked; Precursor Sound Processor, Investigational Device, No preference.

    6 weeks after study start

  • To Assess the Subject's Experience Regarding Comfort

    Measure Comfort by a visual analogue scale (VAS) 100 mm at Day 0 regarding the precursor sound processor and after 6 weeks regarding the Investigational device. Subject will be asked to put a line where they find most appropriate where 0 mm represents Not comfortable at all and 100 represents Most comfortable imaginable. The distance will be measured with a ruler and presented as a value between 0 and 100. A higher score reflects higher comfort.

    Baseline at visit 1, 6 weeks after study start at visit 3

  • To Assess the Subject's Experience Regarding Usage; Magnet Choice

    Magnet choice will be entered; four boxes are available, 1, 2, 3 and 4, the box with the strength chosen by the patient will be ticked. Magnet strength 1 is the weakest and 4 is the strongest.

    6 weeks after study start

  • To Assess the Subject's Experience Regarding Usage; Battery Life Time

    The patient will be asked a question regarding battery life; "How often was the battery changed". A free text field is available for answer.

    6 weeks after study start

  • To Assess the Subject's Experience Regarding Usage; Softwear Pad

    The patient will be asked a question "Did you use a SoftWear Pad in the last 6 weeks". The patient can tick a "Yes" or "No" box.

    6 weeks after study start

  • To Assess the Subject's Experience Regarding Usage; Safety Line

    The patient will be asked a question "Did you use a safety line in the last 6 weeks". The patient can tick a "Yes" or "No" box.

    6 weeks after study start

  • To Assess the Subject's Experience Regarding Usage; Wireless Accessories

    The patient will be asked a question "Did you use a Wireless accessory during the last 6 weeks". The patient can tick a "Yes" or "No" box.

    6 weeks after study start

Study Arms (1)

Investigational device - Sound Processor

EXPERIMENTAL
Device: Investigational device - Sound Processor

Interventions

At visit 1 the subjects will complete self-reported assessments with respect to "pre-study experience" using precursor Sound Processor (comparator). At visit 1 the subjects will then receive the Investigational device (Sound Processor) which should be used during the following 6 weeks. At visit 3 the subjects will complete self-reported assessments regarding Investigational device and participate in audiology tests regarding both Sound Processors, comparator and Investigational device. The subject shall decide their preferred choice made by selection between Investigational device and the comparator.

Investigational device - Sound Processor

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Completed clinical investigation CBAS5539, and an active user of the Osia System.
  • Signed Informed consent.
  • Subject with conductive or mixed hearing loss in the implanted ear. Bone conduction thresholds with pure tone average (PTA4; mean of 0.5, 1, 2 and 4 kHz) of ≤ 55 dB HL.
  • OR subject with single-sided sensorineural deafness. Air conduction thresholds with a pure tone average PTA4 of ≤ 20 dB (decibel) HL (Hearing Level) (mean of 0.5, 1, 2 and 3 kHz) in the good ear.

You may not qualify if:

  • Any ongoing soft tissue complication that could significantly affect the use of the Osia 2 Sound Processor during the 6 weeks period
  • Use of ototoxic drugs that could be harmful to the hearing, as judged by the investigator
  • Unable to follow investigational procedures and instructions, e.g. inability to complete quality of life scales or audiological testing as described in the Clinical Investigation Plan (CIP).
  • Participation in another clinical investigation with pharmaceutical and/or device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HEARing CRC550 Swanston Street, Carlton

Melbourne, Victoria, 3053, Australia

Location

MeSH Terms

Conditions

DeafnessHearing Loss, ConductiveHearing Loss, Mixed Conductive-Sensorineural

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Professor Robert Cowan
Organization
Hearing CRC Melbourne

Study Officials

  • Robert Cowan, Prof

    HEARing CRC550, Carlton, Melbourne

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2019

First Posted

February 21, 2019

Study Start

February 19, 2019

Primary Completion

April 23, 2019

Study Completion

April 23, 2019

Last Updated

October 14, 2021

Results First Posted

February 5, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations